Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies

Based on the success of tumor-infiltrating lymphocytes (TIL)-based therapies, personalized adoptive cell therapies (ACT) targeting neoantigens have the potential to become a disruptive technology and lead to highly effective treatments for cancer patients for whom no other options exist. ACT of TIL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Florian, Klein, Christian, Umaña, Pablo, Gros, Alena, Gasser, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808433/
https://www.ncbi.nlm.nih.gov/pubmed/33520408
http://dx.doi.org/10.1080/2162402X.2020.1869389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808433/
https://www.ncbi.nlm.nih.gov/pubmed/33520408
http://dx.doi.org/10.1080/2162402X.2020.1869389

Ejemplares similares